Literature DB >> 20059603

Advances in the management of inflammatory bowel disease.

F Grimpen1, P Pavli.   

Abstract

Our understanding of inflammatory bowel diseases (IBD) is constantly evolving, and many new treatment options have emerged recently. This review critically examines the evidence for these new developments and aims to provide an overview for medical professionals involved in the care of patients with IBD. Proposed changes in the use of aminosalicylates, immunosuppressants and biological agents are described, and the evidence for several promising novel agents is reviewed.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20059603     DOI： 10.1111/j.1445-5994.2010.02163.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


  3 in total

1.  Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.

Authors:  Bo Xiao; Xiaoying Si; Mingzhen Zhang; Didier Merlin
Journal:  Colloids Surf B Biointerfaces       Date:  2015-08-01       Impact factor: 5.268

2.  Robotic-assisted proctectomy for inflammatory bowel disease: a case-matched comparison of laparoscopic and robotic technique.

Authors:  Aaron T Miller; Julia R Berian; Michele Rubin; Roger D Hurst; Alessandro Fichera; Konstantin Umanskiy
Journal:  J Gastrointest Surg       Date:  2011-10-01       Impact factor: 3.452

3.  Starch nanoparticles improve curcumin-induced production of anti-inflammatory cytokines in intestinal epithelial cells.

Authors:  Norhane Salah; Laurent Dubuquoy; Rodolphe Carpentier; Didier Betbeder
Journal:  Int J Pharm X       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.